Immunicom Hires Former FDA Clinician and Medical Device Reviewer to Rapidly Progress Launch of Novel Cancer Immunotherapy

SAN DIEGO–(BUSINESS WIRE)–Oct 7, 2021– Immunicom, Inc. , a clinical stage biotech pioneering non-pharmaceutical immunotherapies, hires Dr. Christian Shenouda as Vice President of Regulatory Affairs to develop and execute regulatory strategy to integrate the Immunopheresis ® therapy into standard medical practice. Immunicom expects streamlined regulatory approval for the Immunopheresis therapy under the expertise of Dr. Shenouda alongside Immunicom’s three ongoing clinical oncology trials.

Read the source article at businesswire.com
2021-10-07 01:00:00